GSC
DGX icon

G&S Capital’s Quest Diagnostics DGX Stock Holding History

G&S Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.2M Sell
15,108
-184
-1% -$36.1K 0.93% 38
2026
Q1 		$3M Buy
15,292
+179
+1% +$34.8K 1.05% 36
2025
Q4 		$2.62M Sell
15,113
-136
-0.9% -$24.8K 0.93% 43
2025
Q3 		$2.91M Buy
15,249
+8,225
+117% +$1.46M 1.07% 32
2025
Q2 		$1.26M Buy
+7,024
New +$1.22M 0.5% 63

Other funds holding DGX

EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

G&S Capital's DGX Position: Q2 2026 in Review

G&S Capital reduced its Quest Diagnostics (DGX) stake by 1.2% in Q2 2026, selling an estimated $36.1K and leaving 15,108 shares worth $3.2M. The position accounts for 0.93% of the portfolio, ranked #38.

G&S Capital first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 152 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • G&S Capital held 15,108 shares of Quest Diagnostics worth $3.2M as of Q2 2026.
  • G&S Capital sold 184 Quest Diagnostics shares in Q2 2026, an estimated $36.1K.
  • Quest Diagnostics made up 0.93% of G&S Capital's portfolio in Q2 2026, its #38 holding.
  • G&S Capital first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 152 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on G&S Capital's 13F filing for Q2 2026, filed 10 Jul 2026.